COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Annual Reports in Medicinal Chemistry - 1st Edition - ISBN: 9780120405299, 9780080583730

Annual Reports in Medicinal Chemistry, Volume 29

1st Edition

0.0 star rating Write a review
Editor in Chief: James Bristol
Serial Volume Editors: William Hagmann John Lee John McCall Jacob Plattner David Robertson Michael Venuti
eBook ISBN: 9780080583730
Imprint: Academic Press
Published Date: 24th August 1994
Page Count: 397
Sales tax will be calculated at check-out Price includes VAT/GST
72.95
51.06
54.95
161.00
43.99
Unavailable
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

CNS Agents: Third Generation Antidepressants. Neuronal Cell Death. Muscarinic Agonists and Antagonists. Animal Engineering in Neurobiology. Dopamine D[sub]3 and D[sub]4 Receptor Ligands and Pharmacology. Excitatory AminoAcid Research. Cardiovascular and Pulmonary Agents: Endothelin Receptor Antagonists. Treatment of Asthma and Allergy. Nitric Oxide Synthase. Thrombolytic Agents. Antithrombotic and Anti-Inflammatory Agents. Chemotherapeutic Agents: Antibacterial Agents. HIV Reverse Transcriptase Inhibitors. HIV Protease Inhibitors. Antiviral Agents. Opportunistic Infections. Ras Oncogene. Immunology, Endocrinology and Metabolic Diseases: Non-Immunophilin-Related Immunosuppressants. Phosphodiesterase Inhibitors as Antiasthmatic Agents. Human Leukocyte Elastase Inhibitors. Interleukin-1. Cell Adhesion and Carbohydrates. Control of Androgen Action. Topics in Biology: Transcription Factor NF-[lc gr kappa]kB. Translational Control of Gene Expression. Protein Kinases and Phosphatases. Transgenic and Gene Targeting Technology. Osteoporosis. Topics in Drug Design and Discovery: Adenylate Cyclase Subtypes. Advances in Antisense Technology. Prediction of Human Drug Metabolism. Humanized Monoclonal Antibodies. Ethnobotany. Trends and Perspectives: To Market, To Market-1993. Appendices: Compound Name, Code Number, and Subject Index, Volume 29. Cumulative Chapter Titles Keyword Index, Volumes 1-29. Cumulative NCE Introduction Index, 1983-1993. Cumulative NCE Introduction Index, 1983-1993, (Sorted by Indication).


Description

This serial continues to combine regular updates of significant research in medicinal chemistry with emerging research in biological science destined to impact the discovery and development of new medicinal agents.

Readership

Medicinal, pharmaceutical, and organic chemists.


Details

No. of pages:
397
Language:
English
Copyright:
© Academic Press 1994
Published:
24th August 1994
Imprint:
Academic Press
eBook ISBN:
9780080583730

Reviews

@qu:This series is one of the very few annual publications which justify the title of an absolute must for the pharmacologist, chemist, or physician who is interested in the chemistry of drug development." @source:--ENZYMOLOGIA @qu:"This book is strongly recommended for researchers, teachers, students, administrators-in short, anyone whose interests impinge on medicinal chemistry. In view of the work's documented reference value, it is a must for inclusion in the scientist's personal library." @source:--JOURNAL OF MEDICINAL CHEMISTRY @qu:All topics are covered in sufficient depth, with extensive references, to allow either the specialist or the novice to be informed of the latest developments in a particular area of medicinal chemistry. @source:-NORMAN GILMAN, Hoffmann-La Roche, Inc.

Ratings and Reviews


About the Editor in Chief

James Bristol

Affiliations and Expertise

Parke-Davis Pharmaceutical Research

About the Serial Volume Editors

William Hagmann

Affiliations and Expertise

Parke-Davis Pharmaceutical Research

John Lee

John McCall

Jacob Plattner

David Robertson

Affiliations and Expertise

Clinical Research Center, Vanderbilt University, Nashville, Tennessee, U.S.A.

Michael Venuti

Affiliations and Expertise

Arris Pharmaceutical Corporation